
CAS 146019-25-2
:Fórmula:C32H50O5
InChI:InChI=1S/C32H50O5/c1-18-9-12-28(4)15-16-30(6)21(25(28)19(18)2)17-22(34)26-29(5)13-11-24(37-20(3)33)32(8,27(35)36)23(29)10-14-31(26,30)7/h17-19,22-26,34H,9-16H2,1-8H3,(H,35,36)/t18-,19+,22-,23-,24-,25+,26-,28-,29+,30-,31-,32-/m1/s1
Chave InChI:GKZSILIAFXNPRA-GHQZQFNUSA-N
SMILES:C[C@@H]1CC[C@@]2(CC[C@@]3(C(=C[C@H]([C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@H]([C@]5(C)C(=O)O)OC(=O)C)C)C)O)[C@@H]2[C@H]1C)C)C
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 5 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
3-O-Acetyl-11-hydroxy-β-boswellic acid
CAS:3-O-Acetyl-11-hydroxy-β-boswellic acidFórmula:C32H50O5Pureza:≥98%Peso molecular:514.74(3R,4R,6aR,6bS,8aR,11R,12S,12aR,14R,14aR,14bS)-3-Acetoxy-14-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4-carboxylic acid
CAS:Fórmula:C32H50O5Pureza:90%Peso molecular:514.73643-O-Acetyl-11-hydroxy-β-boswellic acid
CAS:3-O-Acetyl-11-hydroxy-beta-boswellic acid is the precursor of 3-O-acetyl-9, 11-dehydro-beta-boswellic acid(a 5-lipoxygenase inhibitor ).Fórmula:C32H50O5Pureza:98.24%Cor e Forma:SolidPeso molecular:514.73643-o-Acetyl-11-hydroxy-beta-boswellic acid
CAS:Produto Controlado3-o-Acetyl-11-hydroxy-beta-boswellic acid is a derivative of boswellic acid, which is a natural phytochemical compound extracted from the resin of the Boswellia species, commonly known as frankincense. The source of this compound, Boswellia, has been traditionally utilized in various systems of medicine for its therapeutic properties. The mode of action of 3-o-Acetyl-11-hydroxy-beta-boswellic acid primarily involves the inhibition of the enzyme 5-lipoxygenase, which is crucial in the biosynthesis of leukotrienes. Leukotrienes are inflammatory mediators that play a significant role in conditions like arthritis and asthma.
Fórmula:C32H50O5Pureza:Min. 95%Peso molecular:514.7 g/mol





